Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.P. Morgan Partners (JPMP) was the private equity and venture capital investment arm of JPMorgan Chase & Co. until its dissolution and spin-off in 2006. The firm was a significant investor in the life sciences, biotechnology, and healthcare sectors, managing a diverse portfolio of growth-stage and buyout investments. In 2006, the JPMP team became independent, forming CCMP Capital for buyouts, while the healthcare venture group spun off to create New Leaf Venture Partners. During its tenure, JPMP provided critical funding and strategic guidance to numerous companies that became leaders in the pharmaceutical and medical technology industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J.P. Morgan Partners.